BIIB vs CRVL · P/E 21, rev $9.89B vs P/E 29, rev $958.5M
Biogen Inc (BIIB) versus CorVel Corp (CRVL) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
CorVel Corp (CRVL) is a insurance brokers company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CRVL revenue for 2026-03-31 was $958.5M. Net income was $110.3M. Revenue was up 7.0% from 2025-03-31 to 2026-03-31. CRVL currently screens at market cap $3.13B and trailing P/E 28.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CRVL currently screens at market cap $3.13B and trailing P/E 28.9.
Not investment advice. Open the BIIB and CRVL stock pages for the full models.
Not investment advice.